Statistics from Altmetric.com
- transcutaneous aortic valve implantation
- valve in valve
- aortic valve disease
- prosthetic heart valves
An 85-year-old man presented acutely with NYHA class IV symptoms requiring continuous intravenous infusion of diuretics over several weeks. Echocardiography showed preserved left ventricular function and a severe central jet of regurgitation through a stented bioprosthetic aortic valve (25 mm Carpentier Edwards, implanted in 1994, Edwards Lifesciences Ltd, Irvine, California, USA) (figure 1A,B, videos 1 and 2). High Euroscore and multiple comorbidities (including chronic cardiac and renal failure) precluded reoperation. Transfemoral transcatheter aortic valve implantation (TAVI) using a self-expanding CoreValve was successfully …
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; not externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.